Literature DB >> 8856539

Dupuytren's disease treated by palmar fasciectomy and an open palm technique.

D L Shaw1, D I Wise, W Holms.   

Abstract

The results of long-term follow-up (range 9-19 years) are presented in a continuous series of patients treated for Dupuytren's contracture by one surgeon using the open palm technique. Mean preoperative total range of movement was 48% rising to 96% postoperatively. Mean total range of movement was 92% at follow-up. Survivorship analysis revealed 86% survival at 10 years and 77% survival at 19 years. There was one digital nerve injury and one case of algodystrophy. This technique gives good long-term results without the use of night splintage or physiotherapy.

Entities:  

Mesh:

Year:  1996        PMID: 8856539     DOI: 10.1016/s0266-7681(96)80051-9

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  5 in total

1.  Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.

Authors:  Keith Denkler
Journal:  Eplasty       Date:  2010-01-27

2.  The tag test for Dupuytren's surgery.

Authors:  C P Charalambous; S P Mills; M J Hayton
Journal:  Hand (N Y)       Date:  2009-03-17

3.  The Wide-Awake Approach to Dupuytren's Disease: Fasciectomy under Local Anesthetic with Epinephrine.

Authors:  Rebecca Nelson; Amanda Higgins; Joanie Conrad; Mike Bell; Don Lalonde
Journal:  Hand (N Y)       Date:  2009-11-10

Review 4.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

Review 5.  What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.

Authors:  Anna L Pratt; Catherine Ball
Journal:  BMC Musculoskelet Disord       Date:  2016-01-13       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.